- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-8190
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chimeric antigen receptor T cell therapy for multiple myeloma ; volume:39 ; number:1 ; day:4 ; month:6 ; year:2019 ; pages:1-5 ; date:12.2019
Inflammation and regeneration ; 39, Heft 1 (4.6.2019), 1-5, 12.2019
- Creator
-
Hasegawa, Kana
Hosen, Naoki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41232-019-0100-6
- URN
-
urn:nbn:de:101:1-2019112819121207347640
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hasegawa, Kana
- Hosen, Naoki
- SpringerLink (Online service)
Other Objects (12)
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Engineering better chimeric antigen receptor T cells
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Optimization of chimeric antigen receptor (CAR) therapy